SANOFI.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 12:59):

Stats
Šios dienos apimtis	8 340.00
Vidutinė apimtis	18 653.00
Rinkos kapitalizacija	190.55B
EPS	INR0 ( 2024-02-23 )
Kita pelno data	( INR0 ) 2024-05-10
Last Dividend	INR183.00 ( 2023-04-28 )
Next Dividend	INR0 ( N/A )
P/E	31.61
ATR14	INR5.33 (0.06%)

Tūris Koreliacija

Ilgas: 0.18 (neutral)

Trumpas: 0.87 (strong)

Signal:(49.238) Same movement expected

Sanofi India Limited Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Sanofi India Limited Koreliacija - Valiuta/Žaliavos

0.41
( neutral )

0.50
( neutral )

0.14
( neutral )

0.32
( neutral )

-0.22
( neutral )

-0.50
( weak negative )

Sanofi India Limited Finansinės ataskaitos

Annual	2023
Pajamos:	INR28.51B
Bruto pelnas:	INR12.40B (43.49 %)
EPS:	INR261.78

FY	2023
Pajamos:	INR28.51B
Bruto pelnas:	INR12.40B (43.49 %)
EPS:	INR261.78

FY	2022
Pajamos:	INR27.70B
Bruto pelnas:	INR15.81B (57.06 %)
EPS:	INR269.47

FY	2021
Pajamos:	INR29.57B
Bruto pelnas:	INR16.50B (55.80 %)
EPS:	INR410.06

Financial Reports:

No articles found.

Sanofi India Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR193.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR183.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Sanofi India Limited Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.09 - Stable (18.23%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR13.50	2003-05-30
Last Dividend	INR183.00	2023-04-28
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	39	--
Total Paid Out	INR1 983.50	--
Avg. Dividend % Per Year	2.98%	--
Score	4.36	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.09
Div. Directional Score	7.59	--

Next Divdend (Est)
(2024-10-07)

INR189.96 Estimate 3.64 %

Dividend Stability

0.29 Very Poor

Dividend Score

4.36

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR71.00	1.47%
2019	INR66.00	1.04%
2020	INR486.00	6.93%
2021	INR240.00	2.90%
2022	INR502.00	6.45%
2023	INR183.00	3.14%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TASTYBITE.NS	Dividend Junior	2023-07-14	Annually	8	0.01%
NH.NS	Dividend Junior	2023-07-06	Sporadic	6	0.14%
IMPAL.NS	Dividend Junior	2023-07-20	Annually	19	1.79%
CHEVIOT.NS	Dividend Junior	2023-08-03	Annually	3	1.62%
SALASAR.NS	Dividend Junior	2023-09-15	Annually	8	1.41%
LUPIN.NS	Dividend Junior	2023-07-14	Annually	23	0.37%
GIPCL.NS	Dividend Junior	2023-09-08	Annually	21	2.50%
ASHIANA.NS	Dividend Junior	2023-09-21	Annually	14	0.37%
TIMETECHNO.NS	Dividend Junior	2023-09-18	Annually	17	0.93%
PARADEEP.NS	No Dividend Player	2023-09-18	Insufficient data to determine frequency	2	0.28%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.211	1.500	5.77	8.66	[0 - 0.5]
returnOnAssetsTTM	0.352	1.200	10.00	10.00	[0 - 0.3]
returnOnEquityTTM	0.645	1.500	3.95	5.92	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.916	0.800	5.42	4.34	[1 - 3]
quickRatioTTM	0.860	0.800	9.65	7.72	[0.8 - 2.5]
cashRatioTTM	0.624	1.500	7.64	10.00	[0.2 - 2]
debtRatioTTM	0.0111	-1.500	9.82	-10.00	[0 - 0.6]
interestCoverageTTM	480.82	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	25.53	2.00	1.490	2.98	[0 - 30]
freeCashFlowPerShareTTM	25.53	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.0187	-1.500	9.93	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.543	1.000	4.28	4.28	[0.2 - 0.8]
operatingProfitMarginTTM	0.287	1.000	6.27	6.27	[0.1 - 0.6]
cashFlowToDebtRatioTTM	3.09	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	1.663	0.800	2.25	1.799	[0.5 - 2]
Total Score				11.10

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	31.61	1.000	6.91	0	[1 - 100]
returnOnEquityTTM	0.645	2.50	6.11	5.92	[0.1 - 1.5]
freeCashFlowPerShareTTM	25.53	2.00	1.490	10.00	[0 - 30]
dividendYielPercentageTTM	0.604	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	25.53	2.00	1.490	2.98	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	2.10	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0206	1.000	-1.984	0	[0.1 - 0.5]
Total Score				4.09

Sanofi India Limited

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.